D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 136.5 SEK 1.49% Market Closed
Market Cap: 2.3B SEK
Have any thoughts about
Devyser Diagnostics AB?
Write Note

Devyser Diagnostics AB
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Devyser Diagnostics AB
Deferred Income Tax Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
D
Devyser Diagnostics AB
STO:DVYSR
Deferred Income Tax
kr200k
CAGR 3-Years
N/A
CAGR 5-Years
189%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Deferred Income Tax
kr15.2m
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Deferred Income Tax
kr1B
CAGR 3-Years
317%
CAGR 5-Years
107%
CAGR 10-Years
51%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Deferred Income Tax
kr6.5B
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
BioArctic AB
STO:BIOA B
Deferred Income Tax
kr12.4m
CAGR 3-Years
-16%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
No Stocks Found

Devyser Diagnostics AB
Glance View

Market Cap
2.3B SEK
Industry
Biotechnology

Devyser Diagnostics AB engages in the development, manufacture and sale of kits for genetic testing in routine diagnostics. The company is headquartered in Hagersten, Stockholm. The company went IPO on 2021-12-10. The products are used for complex deoxyribonucleic acid (DNA) testing in the areas of hereditary diseases, oncology, and post-transplantation monitoring in order to diagnose genetic diseases and target cancer treatment. The firm has since its inception developed and launched almost 30 products for routine diagnostic use, including Devyser Thrombophilia assay as well as Devyser Resolution XY for analysis of chromosomes X and Y. Devyser Diagnostics’ products are sold directly to the end customer or through hired distributors. The firm provides its products in more than 45 countries.

DVYSR Intrinsic Value
123.02 SEK
Overvaluation 10%
Intrinsic Value
Price
D

See Also

What is Devyser Diagnostics AB's Deferred Income Tax?
Deferred Income Tax
200k SEK

Based on the financial report for Dec 31, 2023, Devyser Diagnostics AB's Deferred Income Tax amounts to 200k SEK.

What is Devyser Diagnostics AB's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 5Y
189%

Over the last year, the Deferred Income Tax growth was -39%.

Back to Top